Please assess the completion status of the following clinical trial:

Trial Title: Comparing Autologous Blood, Corticosteroid, and Their Combined Injection for Treating Lateral Epicondylitis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~1-Patients with LE whose complaints persisted for more than 3 months~Exclusion Criteria:~1. Patients with a history of recent trauma,~2. Congenital or neuromuscular disease or abnormality of the upper limb~3. Previous upper limb surgery,~4. History of rheumatic disease,~5. History of cervical disc pathology or carpal tunnel syndrome~6. Systemic corticosteroid treatment~7. Any previous local injection treatment~8. Patients with a history of previous allergic reaction towards local anesthetics and corticosteroids

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 60 Years
- Healthy Volunteers: f

Study Arms:
- Autologous Blood Injection Mixed With Local Anesthetic (Type: ACTIVE_COMPARATOR): Autologous Blood Injection group were administered 1ml of autologous venous blood mixed with 2ml of 2% prilocaine HCl(Priloc %2,Vem,Turkey) subcutaneously.
- Corticosteroid Injection Mixed With Local Anesthetic (Type: ACTIVE_COMPARATOR): Corticosteroid Injection category were given 1ml of 40 mg methylprednisolone acetate(Prednol-L 40mg,Mustafa Nevzat,Turkey) mixed with 2ml of 2% prilocaine HCl(Priloc %2,Vem,Turkey) subcutaneously.
- Combined Injection Mixed With Local Anesthetic (Type: ACTIVE_COMPARATOR): Combined Injection group received a mixture containing 1ml each of autologous venous blood and 40mg methylprednisolone acetate(Prednol-L 40mg,Mustafa Nevzat,Turkey), along with 1ml of 2% prilocaine HCl(Priloc %2,Vem,Turkey) subcutaneously.

Based on this trial design, predict the completion outcome and termination type (if applicable).